Infliximab dose reduction sustains the clinical treatment effect in active HLAB27 positive ankylosing spondylitis: a two-year pilot study (Q37191464)
Jump to navigation
Jump to search
scientific article published on 05 September 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Infliximab dose reduction sustains the clinical treatment effect in active HLAB27 positive ankylosing spondylitis: a two-year pilot study |
scientific article published on 05 September 2013 |
Statements
1 reference
Infliximab dose reduction sustains the clinical treatment effect in active HLAB27 positive ankylosing spondylitis: a two-year pilot study (English)
1 reference
Boel Mörck
5 September 2013
1 reference
1 January 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference